Early- and Late-Stage Kaposi's Sarcoma-Derived Cells But Not Activated Endothelial Cells Can Invade De-Epidermized Dermis  by Simonart, Thierry et al.
Early- and Late-Stage Kaposi's Sarcoma-Derived Cells But
Not Activated Endothelial Cells Can Invade De-Epidermized
Dermis
Thierry Simonart,* Chantal Degraef,² Roger Mosselmans,² Philippe Hermans,³ Yanto Lunardi-Iskandar,§
Jean-Christophe Noel,¶ Jean-Paul Van Vooren,** Dominique Parent,* Michel Heenen,* and Paul Galand²
*Department of Dermatology, Erasme University Hospital; ²Laboratory of Cytology and Experimental Cancerology, Free University of Brussels,
Brussels; ³Department of Infectious Diseases, CHU St Pierre, Brussels, Belgium; §Institute of Human Virology, Baltimore, Maryland, U.S.A.;
¶Department of Pathology, Erasme University Hospital; **Department of Internal Medicine, Erasme University Hospital, Brussels, Belgium
Whether Kaposi's sarcoma is a true neoplasm or a
reactive endothelial cell outgrowth triggered by
in¯ammatory cytokines remains unclear. In this
study, we investigated the differential invasive prop-
erties of activated endothelial cells and Kaposi's
sarcoma cells in a model of de-epidermized dermis,
supplying the cells with matrix barriers similar to
those found in vivo. Cells derived from early ``patch-
stage'' and from late ``nodular-stage'' Kaposi's
sarcoma lesions exhibited similar invasive properties,
which indicates that cells with an invasive potential
are present in the early stages of tumor development.
Slow accumulation of the cells into the extracellular
matrix, together with a low proliferation index and
with expression of anti-apoptotic proteins, suggest
that the progression of Kaposi's sarcoma may be
related to escape from cell death rather than to
increased proliferation. The Kaposi's sarcoma-Y1
cell line, which is tumorigenic in nude mice, also
exhibited invasive properties. By contrast to the
Kaposi's sarcoma-derived spindle cells, however,
which were scattered between the collagen bundles,
the Kaposi's sarcoma-Y1 cell population had a
higher proliferation index and displayed a multilayer
arrangement. In¯ammatory cytokines and Kaposi's
sarcoma cell supernatant could activate and stimulate
the growth of human dermal microvascular endo-
thelial cell, but could not induce their invasion in
this model, showing that activated endothelial cells
do not ®t all the requirements to traverse the various
barriers found in the dermal extracellular matrix.
These results confer to Kaposi's sarcoma cells a
tumor phenotype and suggest that the in vivo domin-
ant endothelial cell population represents a reactive
hyperplasia rather than the true tumor process. Key
words: AIDS/KS-Y1 cell line/92 kDa type IV collagenase.
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K
aposi's sarcoma (KS) is an angioproliferative disease,
which is one of the major neoplasms associated with
the acquired immune de®ciency syndrome (AIDS).
Until the AIDS epidemic, this tumor was identi®ed in
three different settings: classic KS (a slowly growing
tumor particularly prevalent among elderly men of Mediterranean
or Jewish ancestry), African-endemic KS, and immunosuppressive
drug-related KS. All these forms of KS share a similar histopathol-
ogy that has been divided into different progressive stages
correlating with both clinical appearance and progression of the
lesions (Tappero et al, 1993; Calonje et al, 1997). Early ``patch-
stage'' KS lesions are histologically characterized by the prolifera-
tion of small and jagged endothelial lined spaces surrounding
normal dermal vessels. The more advanced stages of KS consist of
the accumulation of spindle-shaped cells, which are considered to
be the tumor cells of KS. The histogenetic origin of these spindle
cells remains controversial. A widely held view is that KS cells
derive from endothelial cells, although they express macrophage
antigens as well as smooth muscle cell and ®broblast markers
(Regezi et al, 1993; Kaaya et al, 1995). In fact, whether KS is a true
neoplasm or a reactive hyperproliferative process remains con-
troversial. KS shows a high incidence of spontaneous remission,
contains low levels of DNA aneuploidy and lacks histologically
discernible neoplastic cells, which would favor a nonmalignant
process (Fukunaga and Silverberg, 1990; Simonart et al, 1997;
Gallo, 1998). The question of the mono- or polyclonality of KS
also remains a matter of discussion (Rabkin et al, 1997; Gill et al,
1998). The current hypothesis to explain the formation and
development of the KS lesions is a multistep pathway involving
cytokine dysregulation, escape from programmed cell death
(apoptosis) and active infection by HIV-1 and/or by a new
herpesvirus designated human herpesvirus 8 (HHV-8) (Chang et al,
1994; Bohan Morris et al, 1996; Foreman et al, 1996; Noel et al,
1996; Pammer et al, 1996; Fiorelli et al, 1998; Simonart et al, 1998;
StuÈrlz et al, 1999; Murakami-Mori et al, 2000), but the pathogenic
links between these steps remain unclear.
In order to clarify the pathogenesis of KS, we and colleagues
have established cultures of spindle cells derived from KS lesions
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(Roth et al, 1988; Nakamura et al, 1988; Benelli et al, 1994; Ensoli
et al, 1994; Pammer et al, 1996; Simonart et al, 1998). Several
®ndings suggest that these cells represent the tumor cells of KS.
They overexpress anti-apoptotic proteins, such as Bcl-2 or BclxL,
and escape apoptosis induced by various apoptotic mechanisms,
indicating that they may have some phenotypic advantage
(Foreman et al, 1996; Mori et al, 1996; Simonart et al, 1998).
They also constitutively produce a 92 kDa type IV collagenase
(Blankaert et al, 1998) and invade reconstituted basement mem-
branes (Albini et al, 1988; Benelli et al, 1994), which suggests they
have an invasive potential. These cells, however, grow transiently
in culture, have rather long doubling times and occasionally show
malignant features such as karyotypic abnormalities and the ability
to produce malignant tumors in immunode®cient mice (Lunardi-
Iskandar et al, 1995; Simonart et al, 1997), illustrating the well-
recognized controversy surrounding the de®nition of KS as a true
neoplasm or hyperplasia. In addition, a mixture of in¯ammatory
cytokines and growth factors has been shown to alter the normal
physiology of endothelial cells, leading to the emergence of
activated cells with phenotypic features similar to those reported for
KS spindle cells, which further suggests that KS may be a cytokine-
mediated reactive process rather than a true neoplasia (Fiorelli et al,
1998). In rare instances, cell lines (e.g., the KS-Y1 cell line) have
been established from patients with highly angiogenic KS lesions
(Lunardi-Iskandar et al, 1995; Gallo, 1998). These cells grow
permanently, induce sarcomas in nude mice, and exhibit common
chromosomal changes. Why these malignant cell clones have been
so rarely isolated so far remains unknown.
One of the characteristic features of malignant tumor cells is their
ability to degrade basement membranes and to migrate/invade into
surrounding tissues. Previous studies have shown that KS-derived
spindle cells and activated endothelial cells can invade reconstituted
basement membranes such as Matrigel (Albini et al, 1988; Benelli
et al, 1994). In this study, we investigated the differential invasive
properties of activated endothelial cells, KS-Y1 cells and spindle
cells derived from early ``patch-stage'' and late ``nodular-stage'' KS
lesions in a model of de-epidermized dermis (DED), supplying the
cells with connective barriers similar to those found in their in vivo
environment.
MATERIALS AND METHODS
Cell cultures Four independent KS cell cultures were derived from
cutaneous KS biopsies from two patients with AIDS (KS-1, early
``patch-stage KS; KS-2, late ``nodular-stage'' KS), from one renal
recipient transplant (KS-3, early ``patch-stage KS) and from one patient
with sporadic KS (KS-4, late ``nodular-stage'' KS). Cultures were
established similarly as previously described (Benelli et al, 1994; Simonart
et al, 1998). Brie¯y, fresh lesions were minced in small pieces and
enzymatically digested with collagenase (1 mg per ml) from Clostridium
histolyticum for 90 min. Cells were grown without additional growth
factors in minimum essential medium D-Val (MEM D-Val) (Gibco,
Paisley, U.K.), which, by contrast to L-valine containing growth media,
may prevent the outgrowth of ``contaminating'' ®broblasts (Picciano
et al, 1985). The medium was supplemented with 10% inactivated fetal
bovine serum (FBS) (Gibco), 1% glutamine, 1% nonessential amino
acids, penicillin (100 U per ml) and streptomycin (100 mg per ml). Cells
isolated from these cultures were characterized as KS cells
morphologically (spindle-shaped morphology) and immuno-
histochemically, as previously described (Simonart et al 2000). In
addition, these cells constitutively produce a 92 kDa type IV collagenase
(Blankaert et al, 1998), which suggests they have an invasive phenotype
and that they may adequately represent the tumor cells of KS. The
experiments presented here were performed on cell cultures between the
®fth and the ®ftieth passage.
The KS-Y1 cells, which display a higher proliferative activity than the
cutaneous KS-derived spindle cells, were established as previously
described (Lunardi-Iskandar et al, 1995). These cells grow permanently in
culture, induce sarcomas in nude mice, and exhibit common chromo-
somal changes (Lunardi-Iskandar et al, 1995). They were maintained in
RPMI (Gibco) containing 10% inactivated FBS (Gibco), 1% glutamine,
1% nonessential amino acids, 1% sodium pyruvate, penicillin (100 U per
ml) and streptomycin (100 mg per ml). No exogenous growth factor was
added.
Human dermal microvascular endothelial cells (HDMEC) were
cultured by a method similar to the one reported by Kluger et al (1997).
HDMEC were isolated from normal adult breast skin obtained as
discarded tissue from reduction mammoplasties (Department of Plastic
Surgery, Erasme University Hospital). Informed consent was obtained
from the patients. Fresh skin was stretched ¯at and sectioned horizon-
tally. After a 80 min incubation in dispase II (2 mg per ml) (Boehringer)
at 37°C, the epidermis was peeled off and cells from both sides of the
underlying epidermis were gently scraped into RPMI (Gibco) and
®ltered through a 70 mM nylon mesh. The ®ltrate, containing single
cells, was washed once in MEM D-Val and plated on to tissue culture
plastic precoated with the cell culture medium (C-22020, PromoCell,
Heidelberg, Germany), supplemented with 10% FBS (Gibco). HDMEC
were allowed to attach approximately 4 h before gentle aspiration (to
remove cell debris) and addition of fresh media. Fluorescence-activated
cell sorter analysis revealed that > 90% of the cells were positive for
endoglin. HDMEC were used at passages 5±9.
Vascular smooth muscle cells were harvested from enzymatically
dissociated human umbilical veins and cultured as described (Lefebvre
et al, 1994). Cells were grown in Dulbecco's modi®ed Eagle's medium
(Biowhittaker, Verviers, Belgium) supplemented with 10% FBS, 1%
nonessential amino acids, penicillin (100 U per ml) and streptomycin
(100 mg per ml).
Human dermal ®broblasts were obtained from human foreskins and
were cultured in RPMI containing 10% inactivated FBS, 1% glutamine,
1% nonessential amino acids, penicillin (100 U per ml), and streptomycin
(100 mg per ml).
Reagents Pentoxifylline was from Hoechst Marion Roussel (Brussels,
Belgium); interleukin (IL)-1b, tumor necrosis factor-a (TNF-a), and
interferon (IFN)-g from Sigma (Bornem, Belgium). The anti-matrix
metalloproteinase (MMP)-9 monoclonal antibody used for the in vitro
invasion assays was from Oncogene Research Products (Cambridge,
MA). It was stored at ±20°C without sodium azide.
Preparation of DED Pieces of DED were prepared as previously
reported (PrunieÂras et al, 1983; Heenen et al, 1992). Strips of skin
obtained from plastic surgery procedures were maintained in phosphate-
buffered solution at 37°C, and epidermis was removed after 5±7 d. The
tissue was killed by 10 successive freeze±thaw procedures followed by g-
radiations (3500 rad). The pieces of DED was then snap-frozen and kept
at ±20°C. By using speci®c antibodies, it was found that the surface of
the DED still reacted positively with antibodies against collagen IV,
indicating that the dermis was still covered by its lamina densa. No
incorporation of [3H]-labeled uridine could be evidenced by
autoradiographs, which, in accordance with previous reports (PrunieÂras
et al, 1983), con®rms that no living cell had remained present.
Cell cultures on to DED Brie¯y, the DED was laid down on a
stainless steel grid and placed on Petri's dishes, as previously reported
(PrunieÂras et al, 1983; De Dobbeleer et al, 1989; Heenen et al, 1992).
The different investigated cells were seeded at 1 3 106 cells in a volume
of 50 ml on the surface of the dermis. For each cell culture, these
experiments were repeated at least three times. To investigate whether
the degradation of the lamina densa was a critical step in the invasion
process, small wells were performed into the surface of DED with a 27-
gauge sterile needle before plating the cells. Some experiments were
performed on DED laid down on the grid with papillar dermis down.
One hour after the plating, culture medium was poured into the dishes
to wet the grids from below. The medium, supplemented or not with
the various reagents, was changed three times a week.
After various periods of incubation at 37°C in 5% CO2 (2 d to
12 wk), the DED samples were ®xed in formalin and processed for
routine histologic examination and immunohistochemistry.
Kinetics of the invasion process To determine the kinetics of the
invasion process, the cells were seeded at 1 3 106 cells in a volume of
50 ml on the surface of 1 cm2 DED. After various periods of incubation,
the samples were formalin ®xed. The number of cells located in the
super®cial portion of DED below the margin was counted by two
investigators in ®ve randomly chosen microscopic ®elds at 250 3
magni®cation. The mean 6 SEM of invading cells was calculated based
on the results of three independent experiments.
Incubation of HDMEC with KS cells supernatants and co-culture
of HDMEC with KS cells Conditioned media from KS cells were
obtained by washing con¯uent KS cell monolayers twice with
phosphate-buffered saline and incubating them for 48 h with serum-free
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MEM D-Val. The supernatants were then collected, centrifuged and
®ltered through 0.45 mm pore size ®lters to eliminate eventual residual
cells and cell debris. The culture medium plus conditioned media from
KS cells was then poured into the dishes and changed three times a
week. Co-culture experiments were performed by seeding 1 3 106
HDMEC on the surface of the DED previously colonized by KS cells.
These experiments were run in quadruplicate (KS-2 cells) or triplicate
(KS-1 and KS-4 cells).
Immunohistochemistry All immunohistochemical studies were
performed on paraf®n-embedded, formalin-®xed DED pieces. Tissues
section were incubated with antibodies against vimentin (V9 clone,
Biogenex, San Ramon, CA), collagen IV (Organon Teknika, Turnhout,
Belgium); laminin (Sigma); a-smooth muscle actin (HHF35 clone,
Biogenex); cytokeratin (AE1AE3 clone, Dako, Glostrup, Denmark);
CD34 (QBEND10 clone, Immunotech, Marseille, France); CD68 (KP1
clone, Dako); von Willebrand factor (BGX016A clone, Biogenex); Bcl-2
(100 clone, Oncogene Research Products); Ki-67 (MIB1 clone,
Immunotech); and MMP-9 (Santa Cruz Biotechnology, Santa Cruz,
CA). The sections incubated with antibodies against Bcl-2, and Ki-67
were treated using the antigen retrieval method as previously described
(Vojtesek et al, 1992). Immunohistochemical staining was achieved with
a standard avidin±biotin peroxidase technique. A tyramide signal
ampli®cation kit (NEN Life Science, Boston, MA) was used for the
detection of MMP-9. Negative controls were provided by replacing the
primary antibody with mouse or rabbit nonimmune serum. The slides
were read blindly by two dermatopathologists, with similar results.
Determination of cytokine levels Commercially available enzyme-
linked immunosorbent assay kits (BioSource, Fleurus, Belgium) were
used for the determination of IL-6 and IL-8 levels in the culture
supernatant.
Detection of viral genomes in KS cells The detection of HHV-8
DNA in KS-derived cells was investigated as previously reported (LebbeÂ
et al, 1995; Simonart et al, 1996). Brie¯y, a 233 bp sized HHV-8
sequence was ampli®ed using the primers KS4 and KS5 described by
Boshoff et al (1995a) as external primers and the primers KS1 and KS2
(Chang et al, 1994) as internal primers.
Statistical analysis The Student's t test (two-tailed) was used to
compare different groups of data, which were obtained from three sets of
experiments.
RESULTS
KS-derived spindle cells exhibit longer doubling times than
their putative endothelial progenitors Doubling times of the
different cell cultures during exponential growth phase are shown
in Table I. All four KS-derived spindle cell cultures studied
exhibited similar growth properties, which is in agreement with
previous studies showing that the spindle cell component of the
different epidemiologic settings of KS shares common biologic
and/or pathologic characteristics (Benelli et al, 1994; Kaaya et al,
1995). As opposed to KS-derived cells and KS-Y1 cells, HDMEC
expanded neither in RPMI nor in MEM D-Val supplemented only
with FBS and amino acids, suggesting that the latter are the most
dependent on exogenous growth factors for growth and survival.
Thus, to minimize potential bias due to different growth medium
compositions, all kinetic and invasive analyses were performed in
the endothelial cell growth medium C-22020. Comparison of the
doubling times revealed that KS-derived spindle cells did not
exhibit a higher growth rate than their putative endothelial
progenitors (Table I). If KS cells are effectively derived from
endothelial cells, our results suggest that this ontogenic evolution
does not involve an enhanced growth potential.
Invasion of DED by KS-derived spindle cells and KS-Y1
cells Both by KS-derived spindle cells and KS-Y1 cells had the
ability to invade DED. The invading KS-derived spindle cells were
mainly located near the margin and retained their spindle-shaped
morphology (Fig 1A). The invasion process was time dependent
(Fig 2). Despite in vitro invasion assays for up to 3 mo, however,
KS-derived spindle cells remained scattered between the collagen
bundles and showed no organization into vascular structures. Both
cells derived from early ``patch-stage'' and from late ``nodular-
stage'' lesions exhibited these invasive properties, suggesting an
effective selection of the KS tumor cells under culture conditions.
The growth pattern of these cells was similar (data not shown). We
also found that AIDS (KS-1 and -2) and non-AIDS (iatrogenic and
sporadic) (KS-3 and -4) KS-derived cells displayed a similar invasive
potential. There was also a time-dependent accumulation of KS-Y1
cells in DED (Fig 2). The density and structure of the invasion
process caused by the KS-Y1 cell line, however, clearly differed
from that seen with the KS-derived spindle cell cultures. By
contrast to the KS-derived spindle cells that were scattered between
the collagen bundles, the KS-Y1 cell population was more dense
and displayed a multilayer arrangement (Fig 1B).
Using an immunohistochemical approach, we found that the
invading KS spindle cells were positive for vimentin, laminin,
collagen IV, a-smooth muscle actin, Bcl-2 protein and negative for
cytokeratin, CD34, CD68 and von Willebrand factor (data not
shown). This indicates that cells in DED express similar markers as
those growing in monolayers, which makes unlikely that a
particular subpopulation making up the cell cultures accounted
for the invasion of the dermis. Iterative counts of the invading
spindle cells (KS-1, -2, -3, and -4) showed a rather slow
accumulation of the cells into the dermis (3±4-fold increase
between the ®rst and third month after DED inoculation). The
absence of cellular debris and of apoptotic body in the extracellular
matrix, together with low number of mitoses and low Ki-67 index
(8 6 5%) of the invading cells, suggests that the slow accumulation
of the cells is related to a low growth rate rather than to a high
death rate. As expected, the KS-Y1 cell population displayed a
higher Ki-67 index (21 6 5%) (p < 0.01).
Using zymographic analysis, we previously demonstrated that KS
cells constitutively release a 92 kDa type IV collagenase, suggesting
that they might be endowed with invasive properties (Blankaert
et al, 1998). Consistent with these results, we found that the spindle
cells invading the dermis reacted with an antibody against 92 kDa
type IV collagenase (Fig 3). Treatment of the cells with a
neutralizing monoclonal antibody against 92 kDa type IV collage-
nase (5 mg per ml) decreased the invasive behavior of KS cells,
suggesting that the expression of this enzymatic activity is involved
in the DED invasion by KS cells. Treatment with the same amount
of isotype-matched control IgG did not inhibit the invasion
process. Incubation of the cells with pentoxi®llyne (5 mM), which
is a known inhibitor of the basal secretion of the 92 kDa gelatinase
(Ries et al, 1994), completely inhibited the invasion of the dermis
by KS-derived spindle cells as well as by the KS-Y1 cell line. The
presence of morphologically intact cells on the surface of the dermis
after this treatment, as well as the re-initiation of the invasion
process after further incubations without pentoxi®llyne, indicates
that the drug probably did not decrease cell viability or adhesion
and suggests a speci®c effect on the penetration process.
Endothelial cells, dermal ®broblasts, and vascular smooth
muscle cells do not invade DED As endothelial cells are
thought to be the KS progenitor cells, we also investigated their
Table I. Doubling times (h) of KS-derived cells, KS-Y1
cells and HDMEC in the different culture mediaa
MEM D-Val RPMI C-22020
KS-1 102 6 26 ND 71 6 16
KS-2 85 6 20 88 6 22 56 6 14
KS-3 95 6 26 ND 69 6 16
KS-4 91 6 25 ND 64 6 15
KS-Y1 37 6 9* 29 6 5* 31 6 6*
HDMEC ‘b* ‘b* 48 6 10
Smooth muscle cells ND ND 72 6 15
Fibroblasts ND 78 6 12 69 6 12
aMean 6 SE (n = 3).
b‘, absence of cell growth.
*p < 0.05. All comparisons were with KS-2 cells and were between cells
cultured in the same culture medium.
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invasive properties. By contrast to KS-derived cells and to the KS-
Y1 cell clone, HDMEC did not penetrate into DED (Fig 1C),
whether or not the lamina densa was perforated before the plating
of the cells. As the ontogenic origin of KS cells remains
controversial and as cultured KS-derived cells may resemble
rather vascular smooth muscle cells or ®broblasts than endothelial
cells (Benelli et al, 1994; Kaaya et al, 1995; Simonart et al, 2000),
we performed invasion assays with those cells. This showed that
dermal ®broblasts and vascular smooth muscle cells also failed to
invade the dermal matrix (Fig 1D, E). The orientation of DED
(reticular dermis up or down) did not appear to play a signi®cant
part in the invasive properties of the cells in any of the cell types
studied. To investigate the role of cell adhesion in the invasion
process, cultured samples were collected and ®xed early (2±3 d)
after the seeding of the cells. The presence of HDMEC spread on
the surface of the dermis (Fig 1C) suggests that a loose adherence
alone cannot explain the differential invasive behavior of
endothelial cells and KS cells.
As in¯ammatory cytokines induce normal endothelial cells to
acquire the phenotypic and functional features of KS cells,
including the expression of type IV collagenases (Blankaert et al,
1998; Fiorelli et al, 1998), we investigated the effect of IL-1b (10±
200 pg per ml), TNF-a (5±50 IU per ml), and IFN-g (1±10 ng per
ml (20±200 IU per ml) on the invasive properties of HDMEC.
Using enzyme-linked immunosorbent assay kits (BioSource,
Fleurus, Belgium), we found, in accordance with other studies
(Sironi et al, 1989), that treatment with IL-1b or TNF-a led to an
effective stimulation of HDMEC, as evidenced by a signi®cant
concentration-dependent release of IL-6 and IL-8 and increase in
ICAM-1 and ELAM-1 expression (data not shown); however,
incubation of HDMEC with various concentrations of IL-1b or
TNF-a did not allow the latter to invade the dermis. Analogously,
IFN-g, which activates endothelial cells and may play a pivotal role
in KS development (Fiorelli et al, 1998), did not induce the
invasion of HDMEC. As previous studies have shown that KS cells
produce a variety of paracrine growth factors for endothelial cells
Figure 1. Invasion of DED by KS cells but
not by activated endothelial cells. (a) KS-2
cells were seeded at 1 3 106 cells in a volume of
50 ml on the surface of DED. One month after
the plating, the samples were formalin ®xed.
Spindle-shaped cells are mainly located near the
margin and are scattered between the collagen
bundles. Note the absence of differentiation in
vascular structures. (b) KS-Y1 cells were seeded at
1 3 106 cells in a volume of 50 ml on the surface
of DED. One month after the plating, the samples
were formalin ®xed. By contrast to KS-derived
cells, the KS-Y1 cells are more dense and display
an epithelium-like differentiation on the surface of
the dermis. (c) KS cell supernatant-activated
HDMEC were seeded at 1 3 106 cells in a
volume of 50 ml on the surface of DED. Presence
of HDMEC on the surface of DED 3 d after the
plating, suggesting that a loose adherence alone
cannot explain the absence of invasion of the
dermis by endothelial cells. (d) Fibroblasts were
seeded at 1 3 106 cells in a volume of 50 ml on
the surface of DED. One month after the plating,
the samples were formalin ®xed. These cells did
not invade the DED. (e) Smooth muscle cells
were seeded at 1 3 106 cells in a volume of 50 ml
on the surface of DED. One month after the
plating, the samples were formalin ®xed. These
cells did not invade the DED. Scale bar: 100 mM.
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(Salahuddin et al, 1988; Ensoli et al, 1994), we next considered the
possibility that conditioned media from KS cells might trigger the
invasion of the dermis by HDMEC. Con®rming previous results
(Simonart et al, 1998), we found that the proliferation of
endothelial cells treated with culture medium plus conditioned
media from KS cells (1:2) was greater than that of endothelial cells
treated with culture medium alone (12% 6 2 vs. 8% 6 2 positive
cells after a 2 h pulse of bromodeoxyuridine) (p < 0.05). Up to
3 mo incubation of HDMEC with KS cell conditioned media,
however, failed to promote their invasion of the dermal matrix.
Analogously, coincubation of HDMEC with KS cells induced
neither the formation of vascular structures nor the penetration of
the endothelial cells, as evidenced by the lack of CD34 and von
Willebrand factor expression. We next proceeded to determine
whether pro-in¯ammatory mediators or IFN-g could promote the
invasion of ®broblasts or vascular smooth muscle cells into DED.
This indicated that neither IL-1b (10±200 pg per ml), nor TNF-a
(5±50 IU per ml), nor IFN-g (1±10 ng per ml) did induce these
cells to invade DED.
Absence of viral genomes in KS cells Con®rming previous
studies (LebbeÂ et al, 1995; Simonart et al, 1996), we found that the
HHV-8 DNA sequences were lost in KS cell cultures. We also
failed to detect Tat or Tax proteins in KS-derived cells, which is in
agreement with other studies demonstrating neither HIV nor
HTLV sequences in KS-derived cells.
DISCUSSION
One of the characteristic features of malignant tumors is invasion
into surrounding tissues. The most widely used models for
evaluating cell invasion in vitro are collagen gels, which have
allowed to show that KS-derived cells and activated endothelial
cells traverse reconstituted basement membranes (Albini et al, 1988;
Benelli et al, 1994). In this study, we investigated the invasive
properties KS-derived cells in a model of DED, originally used for
the study of keratinization disorders (PrunieÂras et al, 1983; De
Dobbeleer et al, 1989; Heenen et al, 1992). The advantage of this
model is that it supplies the cells with connective barriers similar to
those found in the in vivo environment. We have found that KS-
derived cells can migrate and invade into surrounding dermis in a
time-dependent manner. Both cells derived from early ``patch-
stage'' and from late ``nodular-stage'' KS lesions exhibited these
invasive properties, suggesting that cells with a malignant potential
are present in the early stages of tumor development. Interestingly,
we have found that AIDS-related KS-derived cells as well as cells
derived from iatrogenic and from sporadic KS displayed these
invasive properties. These ®ndings support the view that the
different epidemiologic forms of KS represent a uniform disease
spectrum with common pathogenic denominators and indicate that
invasion into surrounding dermis may be a crucial step in the
pathogenesis of the tumor. Although HIV-1 Tat protein is a well-
known promotor of KS cell invasion and migration (Colombini
et al, 1998), these observations also suggest that KS-derived spindle
cells have intrinsic invasive properties independently of HIV
products. The invading spindle cells had a phenotype similar to that
Figure 2. Time-dependent accumulation of KS cells in DED. KS-
2 cells (n) and KS-Y1 cells (d) were seeded at 1 3 106 cells in a
volume of 50 ml on the surface of 1 cm2 DED. After various periods of
incubation, the samples were formalin ®xed. The number of cells located
below the margin was counted in ®ve randomly chosen microscopic
®elds at original magni®cation, 3 250. The results are expressed as the
mean 6 SEM of the cell number from three independent experiments.
Figure 3. Staining of the invading KS-derived spindle cells with
an anti-92 kDa type IV collagenase monoclonal antibody.
Immunoperoxidase staining: brown reaction signi®es positive detection
of the speci®c antigen. (a) Control isotype. (b) Detection of the 92 kDa
type IV collagenase in the cytoplasm of the cells. Scale bar: 40 mM.
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of the original cell cultures, which argues against the possibility that
a particular subpopulation making up the cultures might be solely
responsible for the invasion of the dermis. Despite long in vitro
invasion assays (up to 3 mo), the invading cells remained scattered
into the volume of the dermis pieces. The low growth rate of these
invading spindle cells is consistent with in vivo observations showing
a low proliferation fraction and a low number of mitoses in KS
lesions (Calonje et al, 1997; De Thier et al, 1999), suggesting that
the tumoral progression of KS may be related to escape from cell
death rather than to increased proliferation. This hypothesis is
further supported by the expression of anti-apoptotic proteins, such
as Bcl-2, by the spindle cells (Bohan et al, 1996; Simonart et al,
1998). These invasive properties were shared by the KS-Y1
neoplastic cell line, which is in line with previous observations
showing that, in contrast to KS-derived spindle cell cultures, this
cell clone may invade the subcutaneous tissue and induce tumor
growth in nude mice (Lunardi-Iskandar et al, 1995). The behavior
of the KS-Y1 in the DED was, however, markedly different from
that of KS-derived spindle cells. First, the invading KS-Y1 cells
were more dense, which could be related to their higher
proliferation index. Secondly, the KS-Y1 showed a multilayer
arrangement suggestive of epithelial differentiation. The reasons for
this particular arrangement are currently unknown.
The ontogenic origin of KS tumor cells remains controversial.
Although it is commonly assessed that KS cells derive from
endothelial cells (Regezi et al, 1993), cultured KS cells may have
phenotypic features closer to those of ®broblasts or of vascular
smooth muscle cells than to those of endothelial cells (Benelli et al,
1994; Kaaya et al, 1995; Simonart et al, 2000). Here, we found that
by contrast to KS-derived spindle cells and to the KS-Y1 cell clone,
neither ®broblasts, nor smooth muscle cells nor HDMEC could
invade DED.
Using immunohistochemistry, we found constitutive expression
of 92 kDa type IV collagenase by KS and KS-Y1 cells. This enzyme
is thought to play a crucial part in the process of invasion and
metastasis because a strong correlation between constitutive 92 kDa
type IV collagenolytic activity and invasive potential has been
shown for various human tumor cells (Liotta et al, 1991). Decreased
KS cell invasion was observed after treatment of the dermis with a
neutralizing monoclonal antibody to 92 kDa type IV collagenase,
suggesting that the expression of this enzymatic activity plays a key
part in the invasive phenotype of KS cells. Similar results were
obtained after treatment of the dermis with pentoxi®llyne, a
nonspeci®c inhibitor of the secretion of the 92 kDa gelatinase,
which might act through inhibition of autocrine production of
TNF-a (Ries et al, 1994). Interestingly, in¯ammatory mediators,
such as cytokines, have been reported to induce the expression of
collagenolytic activity in endothelial cells (Hanemaaijer et al, 1993;
Cornelius et al, 1995; Blankaert et al, 1998), strengthening the
hypothesis that KS cells have features of activated endothelial cells
(Fiorelli et al, 1998). Furthermore, KS cell supernatants have been
shown to induce the invasion of endothelial cells through
reconstituted basement membranes (Thompson et al, 1991).
HDMEC activated by pro-in¯ammatory mediators, however,
such as IL-1b, TNF-a, and IFN-g or by KS-conditioned media
were unable to invade the DED. Analogously, these mediators did
not induce ®broblasts and vascular smooth muscle cells to invade
DED, clearly indicating that cultured KS-derived cells are not
merely activated ®broblasts. This may suggest a suboptimal
inducible expression of the gelatinolytic and/or interstitial
collagenolytic activities. Another possibility is that speci®c factors
not directly related to these enzymatic activities are involved in this
invasion process of DED. An ``activated'' pattern of integrin
expression is known to occur in AIDS KS lesions (Barillari et al,
1993; Ensoli et al, 1994). Further studies are required to determine
if a constitutively altered integrin expression pattern may account
for the intrinsic invasive properties of KS cells.
Con®rming previous studies, we found that neither KS-derived
spindle cells nor the KS-Y1 cell clone exhibit HHV-8 DNA
sequences (LebbeÂ et al, 1995; Simonart et al, 1996; Gallo, 1998),
indicating that the differential invasive properties of KS cells and
HDMEC are not related to the presence of the virus. Although
HHV-8 is clearly linked with KS, contains transforming genes (e.g.,
the open reading frame 74 and K12) and encodes for homologs of
proteins involved in the control of apoptosis, differentiation, and
cell proliferation (Cesarman et al, 1996; Neipel et al, 1997; Sarid
et al, 1997; Bais et al, 1998; Muralidhar et al, 1998), its causal role in
KS pathogenesis remains unclear. Although not entirely conclusive,
in situ analyses indicate that the virus may infect spindle cells,
endothelial cells, B lymphocytes, and in®ltrating monocytes and
macrophages (Boshoff et al, 1995b; Blasig et al, 1997; Orenstein
et al, 1997). If HHV-8 may effectively infect the KS spindle cells,
our present results demonstrate that its presence is not necessary for
their invasive behavior. This may suggest that the virus does not
principally target the KS tumor cells but other cell types in the
lesions; e.g., endothelial cells whose growth has been clearly shown
to be promoted by the virus, or mononuclear cells, which might be
induced to release pro-angiogenic factors in response to HHV-8
infection (Fiorelli et al, 1998; Flore et al, 1998). Another possible
explanation is that the virus acts in spindle cells through a ``hit and
run'' mechanism (Ambinder, 2000).
In conclusion, we have shown that KS-derived spindle cells can
intrinsically invade DED, independently of their epidemiologic
setting and histologic stage. The long doubling time of the invading
cells, together with the expression of anti-apoptotic proteins
suggest that the accumulation of these cells in KS lesions may be
related to escape from cell death rather than to increased
proliferation. Although KS cell products can effectively activate
endothelial cells, they failed to induce their invasion in this model,
suggesting that activated endothelial cells do not ®t all the
requirements to traverse the various barriers found in the dermal
extracellular matrix. These results suggest that the in vivo dominant
endothelial cell population represents a reactive hyperplasia rather
than the true tumor process. The model of DED invasion described
here should facilitate further studies on the progression of KS
lesions.
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